Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

NCT06275906 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-04-20

No results posted yet for this study

Summary

The study in question is an interventional study with nutritional intervention.

The aim of the study is to evaluate whether the adoption of two different models of Mediterranean Diet, based on the different percentage of carbohydrates and lipids, associated with a program of moderate intensity aerobic physical exercise, in patients with obesity and NAFLD can exercise, after only 3 months, effects on:

* specific aspects associated with NAFLD, such as the degree of hepatic steatosis and fibrosis;
* circulating levels of molecules correlated with the degree of generalized and hepatic inflammation and the blood concentrations of metabolic and cardiovascular risk factors associated with abdominal obesity;
* intestinal barrier;
* body composition;
* intestinal microbiota;
* symptoms of IBS (irritable bowel syndrome) in patients with NAFLD.

Conditions

Interventions

OTHER

Mediterranean diet and moderate intensity physical exercise (outdoor walking).

Mediterranean Diet, based on the different percentage of carbohydrates and lipids, associated with a program of moderate intensity aerobic physical exercise (outdoor walking), in patients with obesity and NAFLD.

Sponsors & Collaborators

  • Russo Francesco

    collaborator UNKNOWN
  • Cozzolongo Raffaele

    collaborator UNKNOWN
  • Shahini Endrit

    collaborator UNKNOWN
  • Zappimbulso Marianna

    collaborator UNKNOWN
  • Giannuzzi Vito

    collaborator UNKNOWN
  • De Nucci Sara

    collaborator UNKNOWN
  • Rinaldi Roberta

    collaborator UNKNOWN
  • Sila Annamaria

    collaborator UNKNOWN
  • Tatoli Rossella

    collaborator UNKNOWN
  • Cerabino Nicole

    collaborator UNKNOWN
  • Donghia Rossella

    collaborator UNKNOWN
  • Franco Isabella

    collaborator UNKNOWN
  • Bianco Antonella

    collaborator UNKNOWN
  • Curci Ritanna

    collaborator UNKNOWN
  • Bagnato Claudia Beatrice

    collaborator UNKNOWN
  • Sciarra Sabrina

    collaborator UNKNOWN
  • Prospero Laura

    collaborator UNKNOWN
  • Serino Grazia

    collaborator UNKNOWN
  • Scalavino Viviana

    collaborator UNKNOWN
  • Piccinno Emanuele

    collaborator UNKNOWN
  • Pesole Pasqua Letizia

    collaborator UNKNOWN
  • Coletta Sergio

    collaborator UNKNOWN
  • Stabile Dolores

    collaborator UNKNOWN
  • Riezzo Giuseppe

    collaborator UNKNOWN
  • Ancona Anna

    collaborator UNKNOWN
  • D'Attoma Benedetta

    collaborator UNKNOWN
  • Ignazzi Antonia

    collaborator UNKNOWN
  • Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-19
Primary Completion
2025-04-08
Completion
2026-04-08

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06275906 on ClinicalTrials.gov